MAPT and Alzheimer disease: Since the typical pathological feature of AD is amyloid β (Aβ) protein deposition and Tau protein hyperphosphorylation, current studies on humoral diagnostic markers for AD mainly focus on the levels of Aβ and Tau protein-related markers in cerebrospinal fluid (CSF) and blood (Bjerke and Engelborghs, 2018).